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Abstract  
Brazil has republished several normative instructions for the last months related to medicinal plants and herbal medicines in accordance to public policies 
which encourage the use of herbal medicines that present safety, efficacy, and quality patterns. This article reports the last published rules and their major 
changes comparing to the previous ones. 
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Resumen 
Brasil acaba de publicar varias normas relacionadas con las plantas medicinales y fitoterápicos con el fin de satisfacer las demandas de las políticas públicas 
vigentes en el país y fomentar la entrada de medicamentos a base de hierbas con la seguridad, eficacia y calidad para la población. Este artículo presenta las 
normas recientemente publicadas y presenta los cambios más importantes. 
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Since 1967, Brazilian health policies have 
recognized the role of medicinal plants in the Public 
Health scenario, publishing specific regulations for 
herbal medicines regarding certain aspects such as 
safety, quality, and efficacy (BRASIL, 1967). Table 1 





Table 1. Mainly Brazilian specific guidelines about medicinal plants regulation 
Category Legal Basis Main features Link 
Medicinal Plants Law 
5991/1973 
Controls medicines trade, 














Approves the national policy of 







Determines monitoring of medicines, 
pharmaceutical supplies, drugs, 




Herbal medicines RDC 14/2010 Regulates herbal medicines register http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res
0014_07_01_2010.html 
Herbal medicines IN 05/2010 List of references to evaluate safety and 
efficacy of herbal medicines 
http://www.in.gov.br/imprensa/visualiza/index.jsp?data=
05/04/2010&jornal=1&pagina=91&totalArquivos=160 
Herbal medicines IN 05/2008 List of plants with simplified register ftp://ftp.saude.sp.gov.br/ftpsessp/bibliote/informe_eletron
ico/2008/iels.dez.08/iels236/U_IN-ANVISA-
5_111208.pdf 
Herbal medicines RE 90/2004 Guide to toxicological test to herbal 
medicines 
http://www.abrafito.org.br/legislacao.shtml#005 
Herbal medicines RE 91/2004 Guide for changes on herbal medicines 
register 
http://www.abrafito.org.br/legislacao.shtml#005 
Pharmaceuticals RDC 17/2010 GMP for medicines  http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res
0017_16_04_2010.html 
Herbal medicines RDC 10/2010 Herbal drugs notification http://www.brasilsus.com.br/legislacoes/rdc/103202-10 
MS: Health Ministry; GM: ANVISA Pharmaceuticals Bureau; RDC: Resolution; IN: Normative Instruction; RE; Resolution from ANVISA 
Council 
 
Therefore, the regulation of herbal medicine and 
medicinal plants largely evolved in the last decade, 
stimulated by the foundation of the Agência Nacional 
de Vigilância Sanitária - ANVISA, and by the 
implementation of the National Policy of Integrative 
and Complementary Practice and National Policy of 
Medicinal Plants and Herbal Medicines (BRASIL, 
2006a, 2006b; Carvalho et al., 2007; Carvalho et al., 
2008). One of the most recent regulations is the RDC 
number 14, published on April 05th, 2010 (BRASIL, 
2010d), which updated the technical requirements for 
industrialized herbal medicine registration. Indeed, 
few changes can be noted when comparing the latter 
to the previous guideline (RDC 48/2004) (BRASIL, 
2004) concerning the requirements to prove efficacy 
and safety patterns. The demand on safety and 
efficacy patterns still remains and they must be 
preceded by pre-clinical and clinical tests. The results 
must also be supported by scientific literature or 
traditional use of the plant species. A list of 
references that support the plant’s safety and efficacy 
patterns was published again as IN 05/10 (BRASIL, 
2010c). 
However, the new document includes 
innovations in the requirements for quality control. 
The Biological control is a new alternative to replace 
the chemical marker control for in vivo, ex vivo or in 
vitro validated tests, controlling the activity of the 
herbal medicine. Other inclusions refer to the need to 
evaluate the aflatoxins as recommended by the WHO 
magazine reports (WHO, 2007).  
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One innovative inclusion is the requirement to 
register alga and multicellular fungus based products 
as ANVISA is defining the specific guidelines for 
this purpose. There was a lack of requirements in 
order to register these sorts of products and the RDC 
14/2010 filled in this gap. Another innovation is the 
possibility for an herbal drug to become the active 
substance in the herbal medicine, if its efficacy can 
be clinically tested and proved. Herbal drug 
registration was prohibited by the preceding rule 
(RDC 48/2004). 
One of the several aspects that show the 
evolution of the Brazilian regulation in this field is 
the obligation to present pharmacologic surveillance 
reports for renewing herbal medicine registration in 
order to monitor adverse effects related to the herbal 
medicine in question. 
The new regulation norms also affect imported 
herbal medicines. The authorization to import 
samples of herbal medicines can be done prior to 
their registration in order to process batch-to-batch 
quality analyses and clinical tests. Such analyses can 
be done by a third party Quality Control laboratory in 
Brazil instead of by a laboratory from the samples’ 
home country as long as the laboratory hired to 
perform these tests has herbal medicine certifications 
from Good Laboratory Practices – GLP and Good 
Manufacturing Practices - GMP (BRASIL, 2010b). 
Good Manufacturing Practices guideline was also 
updated on April 19th by RDC number 17/2010. This 
guideline brings specific requirements for herbal 
medicine industries. The normative requires technical 
qualification on herbal medicine aspects for all those 
involved in the manufacturing/inspection/liberation 
of these products. Other innovations added to this 
guideline are the mandatory control of pesticides and 
fumigant residues in final products and the rules 
about genetically modified herbal drug 
manufacturing (BRASIL, 2010a) 
Two other guidelines were recently published. 
The RDC 47/2009 defines the rules on elaborating, 
harmonizing, improving, and publishing literature to 
inform patients and health professionals about herbal 
medicines and their rational use (BRASIL, 2009a). 
The other guideline, RDC 71/2009, defines the 
requirements of labeling all pharmaceutical products 
that are registered and sold. The labels must also be 
written in Braille and must have a tracking system, 
along with other requirements (BRASIL, 2009c). 
Another newly published regulation, the RDC 
10/2010, from March 10th, deals with herbal drugs 
that are used in medicinal teas and has, therefore, 
filled in another gap in the Brazilian regulation. With 
this norm, the industries can now register their herbal 
drug productions based on a list of 66 traditionally 
recognized as efficient and safe herbal species 
(BRASIL, 2010b). 
CONCLUSIONS 
All these new rules present an evolution to the 
Brazilian Regulation. However, even though the 
innovated sanitary regulation meets the Public Health 
Policies for Industries it is mandatory to carry on 
researches in order to appraise the Brazilian 
medicinal plants accordingly, as established by the 
Relação Nacional de Plantas de Interesse para o 
Sistema Único de Saúde (RENISUS) (BRASIL, 
2009b).  
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